Member Info for TWatcher

such a valuable well researched thread by the long term serious investors. really adding to the discourse and discussion.

"TW - can forecasts and plans not change if the government changes its requirements?"

Indeed they can, ODX this time last year was confident that they'd be shipping bucket loads of antibody tests in a matter of months.

But you have to ask, if the CEO is correct, why did the DHSC ask for home use approval for the biosure product, and not the RTC product that has been there for a year. And if the CEO is incorrect, that approval for home use is not prerequisted on the DHSC asking the MHRA to do so, why is he misinformed.

The CEOs assessment of the opportunities in the UK for the RTC test were not fantastic

He said: "Clearly the uk is not a market where we will see a huge amount of revenue, for reasons already given and that the vaccination program has been done at such a pace" (34:30 in the presentation video)"

And in terms of getting self test approval, question 95 is particularly revealing

Q95: really?! The MHRA only approve if the DHSC needs a test? The MHRA are an independent body. How does that make any sense? Any documents to support this answer please?
The MHRA does not provide home-use approval for COVID-19 antibody tests independently from a request from the DHSC for a derogation to allow home-test use. The UK RTC cannot seek home use approval in the UK independently so it relies entirely on the UK Government requesting this – which is what they did for the 1m tests supplied for the surveillance study"

So he states as fact that the consortium can not ask for home approval, and that categorically the MHRA does not give approval of home antibody testing unless the DHSC asks for it. So If he is factually correct, then the DHSC must have asked for home approval for the Biosure test. If he is wrong, what does that say for his understanding of the uk approval processes.

Either way, He stated for several reasons that uk is not a market for the RTC-19 tests in significant volume. the £124M contract for lab based testing (test at home send to lab), and the home approval out of nowhere for the biosure test, in preference to the RTC-19 test would evidence that.

CK did say that 3 countries were imminent in July, although that turned into "soon" in the email. Abingdon didn't express the same excitement in their trading update a week ago that said

"The Company has not seen significant commercial traction with the AbC-19(TM) product to date but remains encouraged by the ongoing discussions in various overseas territories as well as the potential development of a consumer market, both within the UK and internationally, with the general public wanting to know their antibody status. Abingdon is actively working with commercial partners on securing these opportunities. "

No timelines, no imminent, no soon. And they of course are now the exclusive worldwide manufacturer of the biosure antibody test. They also have a major chip on their shoulder regarding the ABC test, still waiting for £5M, cited the RTC-19 issues as reason for making 60 people redundant. And this is the group with sole responsibility for garnering sales of it !

First comment of the day from that particular LTH is to comment on the people that he's apparently filtering. Not analysis, commentary or research on the company, no, just get a snark out there first thing.

its a conspiracy I tell ya !

https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/national-standardised-test-performance-process-for-manufacturers-of-sars-cov-2-virus-antibody-tests

Is this a new page that's been added ?

Updated 20th of August, but the included table references 29th of March, when there were 5 antibody tests that had registered interest, but non completed ?

"Holding patiently."

Suonded much more like "holding impatiently"

" So, what is AbC-19 approved for? Prof use only?"
Has been since 30th July 2020.

"Are we now saying that the UK RTC product AbC-19, is not going to get home use approval"
CEO said mid-july there was no requirement from DHSC for a home test product and this was a prerequisite to MHRA approval. The subsequent news that Biosure has received it just a few weeks later would lead you be believe that he was mis-informed or out of the loop.

Appears to me the whole ABC-19 /GLP thing has made this product too toxic for the gov to be anywhere within 100 yards of. Why that means it can not get self-test approval for retail use I do not know , possibly because the terms of the original agreement meant that the gov gets a small kick-back per unit sold and would not look good to approve a product they will profit from, whilst the tender process is still in court ?

Meanwhile ABDX had to make 60 people redundant because of it, and have TT the biosure antibody product as the sole worldwide manufacturer, they clearly don't think their capacity is going to be tied up making RTC antibody tests. I assume it is up to ABDX to apply/re-apply for home use, if they are inclined to do so ?

Looks like a mess.

the antibody "base" has been covered for over a year at this stage:-

30th July 2020
" Abingdon Health Limited, as lead partner of the UK-RTC, has today confirmed that it has CE-Marked the AbC-19(TM) Rapid test for professional use. "
"To achieve self-testing accreditation, pre-approval from the MHRA is required to perform self-test usability studies. The planned study will be performed by Ulster University using approximately 2,000 volunteers and, once complete, will allow the UK-RTC to seek final approval from the MHRA for self-test use. In addition, the test will also be subject to further independent evaluation. "

The biossure product came out of nowhere and has got full home-use approval, whereas CK told us last month that the DHSC 'clearly' had no requirement for home use and that was a prerequisite for MHRA approval for home use.

"All I know is that certain people are obsessed with him "

Stones should not be thrown in-doors, full stop.

Agree that a favourable report from the trial (and given ODX are paying for it, it'll be favourable), will be +ve newsflow.

The real newflows is HMG test selection being advised to ODX, whether it's visitect or a 3rd party. Assuming either of those happens, then it starts a new timeline that has certainty to it.

How man threads have I started in my name....err...none ever. All these people starting thread about me, and yet all these people have me filtered apaprently. Some are fixated.

So Am I notorious shorter today or 10p a post guy today, I didn't get the last update :)

Lewis99
Today 15:46
Posts: 237
Price: 48.50
No Opinion

£6.00

One hell of a rise for sure.

I see lewis on another thread is aiming for £6, that's quite a road to damascus he's on.

14:40
1)Seems a bit leaky. People in the group seem to think news is on route. I have therefore taken a nice position.

15:47
2)Main reason for buying in is its oversold and should imo now bounce to around 60 without news.

15:46
3)£6.00

I'm guessing he'll immediately be inducted into the telegram group as a serious long term investor :)

"They shouldn’t base their investment decisions from reading your comments. "

"don't base share dealing decisions.....either one way or the other"

is what I said........such is the myopic nature of some, they can't even wait to get to the end of the sentence before smashing the reply button.

"regarding MHRA Home use, if you find disclosure that Biosure have secured private purchase home use please share"

Okehurst1, anybody can buy them on the biosure.com website, "CE Marked specifically for self-testing", "free standard uk delivery included" (£32.95 each !)

whereas the RTC test on the same website is "enquire now", "For Professional Use Only - NOT SUITABLE FOR SELF TESTING"

So you'll need to verify you are a professional before you order the RTC test, but any joe bloggs can order the biosure test. It would illegal to do direct sales if they had no authorisation in the UK to do so. Hence why the RTC test ISN'T available for immediate purchase.

That's about as clear as it can get.

Lewis99...ummm...don't base share dealing decisions on "seem to think" that you find in here, either one way or the other.

Some people in this group thought ODX made 2M a week in April, long after it was patently clear that they didn't.

Okehurst1

Do you agree that the biosure website shows you that every significant piece of the kit is different between the biosure kit and the RTC kit, and that in their press release, abingdon said they had to do a full 3 stage technical transfer and hence this is clearly NOT a rebadged RTC test ?

Also abingdon in their press release said "For individuals to be able to monitor their own antibody status at home is a great step in the management of COVID-19."

Abingdon also makes the biosure HIV test, which uses the same barrel test, and also has home test approval.